165 related articles for article (PubMed ID: 15753989)
21. Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat.
Brown LA; Nunez DJ; Brookes CI; Wilkins MR
Cardiovasc Res; 1995 Jun; 29(6):768-74. PubMed ID: 7656280
[TBL] [Abstract][Full Text] [Related]
22. ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
Smollich M; Götte M; Fischgräbe J; Macedo LF; Brodie A; Chen S; Radke I; Kiesel L; Wülfing P
Breast Cancer Res Treat; 2010 Sep; 123(2):345-57. PubMed ID: 19943105
[TBL] [Abstract][Full Text] [Related]
23. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
24. [The study of endothelin and endothelin receptors in cyclic human endometrium].
Wang G; Zheng S; Fan Z
Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):594-6. PubMed ID: 10806683
[TBL] [Abstract][Full Text] [Related]
25. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
26. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
27. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
28. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels.
Bellahcène A; Antoine N; Clausse N; Tagliabue E; Fisher LW; Kerr JM; Jarès P; Castronovo V
Lab Invest; 1996 Aug; 75(2):203-10. PubMed ID: 8765320
[TBL] [Abstract][Full Text] [Related]
29. Expression of sigma 1 receptor in human breast cancer.
Wang B; Rouzier R; Albarracin CT; Sahin A; Wagner P; Yang Y; Smith TL; Meric-Bernstam F; Marcelo Aldaz C; Hortobagyi GN; Pusztai L
Breast Cancer Res Treat; 2004 Oct; 87(3):205-14. PubMed ID: 15528963
[TBL] [Abstract][Full Text] [Related]
30. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1.
Wilson JL; Burchell J; Grimshaw MJ
Cancer Res; 2006 Dec; 66(24):11802-7. PubMed ID: 17178876
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of breast cancer cell lines by a low-density microarray.
de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
[TBL] [Abstract][Full Text] [Related]
32. Endothelin-1 stimulates human adipocyte lipolysis through the ET A receptor.
Eriksson AK; van Harmelen V; Stenson BM; Aström G; Wåhlén K; Laurencikiene J; Rydén M
Int J Obes (Lond); 2009 Jan; 33(1):67-74. PubMed ID: 18982011
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
[TBL] [Abstract][Full Text] [Related]
34. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
[TBL] [Abstract][Full Text] [Related]
35. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up.
Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Rody A; Greb RR; Böcker W; Kiesel L
Clin Cancer Res; 2003 Sep; 9(11):4125-31. PubMed ID: 14519635
[TBL] [Abstract][Full Text] [Related]
36. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion.
Smollich M; Götte M; Kersting C; Fischgräbe J; Kiesel L; Wülfing P
Breast Cancer Res Treat; 2008 Mar; 108(2):175-82. PubMed ID: 17468950
[TBL] [Abstract][Full Text] [Related]
37. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
38. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
39. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
[TBL] [Abstract][Full Text] [Related]
40. Distinct patterns of endothelin axis expression in primary prostate cancer.
Godara G; Pecher S; Jukic DM; D'Antonio JM; Akhavan A; Nelson JB; Pflug BR
Urology; 2007 Jul; 70(1):209-15. PubMed ID: 17656249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]